companydata.dkcompanydata.dk

BIOMEDIQ A/S: Financial statements 2016

CVR: 31176891

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

BIOMEDIQ A/S (CVR 31176891) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 2,981,218 and a net result of DKK -915,374 compared with DKK -203,231 the year before. That is a decrease of 55.9% compared with the year before. The profit margin was -30.7%. Equity in the 2016 report amounted to DKK 367,286. The solvency ratio was 9.4%. The company had 5 employees in the financial year.

Revenue
DKK 2,981,218
Gross Profit
DKK 1,562,227
Profit/Loss
DKK -915,374
Equity
DKK 367,286
Total Assets
DKK 3,893,608
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20163M1.6M-915K367K5
20156.8M4.6M-203K1.3M-
20147.5M5M51K1.5M-
20135.9M3.6M24K435K-
20126.6M3.5M51K410K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like BIOMEDIQ A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2016

BIOMEDIQ A/S: The 2015 annual report is outJun 17, 2016

BIOMEDIQ A/S has published its annual report for 2015. Revenue came to DKK 6,753,937, and the net result was DKK -203,231.

BIOMEDIQ A/S appoints new auditorMay 18, 2016

As of May 18, 2016, AIDER Godkendt Revisionsaktieselskab has been appointed auditor of BIOMEDIQ A/S.

Auditor steps down at BIOMEDIQ A/SMay 18, 2016

As of May 18, 2016, CARSTEN C. HOFF REGNSKAB ApS has stepped down as auditor of BIOMEDIQ A/S.

Claus Henrik Christiansen leaves the board of BIOMEDIQ A/SApr 25, 2016

As of April 25, 2016, Claus Henrik Christiansen has left the board of directors of BIOMEDIQ A/S.

Thomas Nielsen leaves the board of BIOMEDIQ A/SApr 25, 2016

As of April 25, 2016, Thomas Nielsen has left the board of directors of BIOMEDIQ A/S.

About BIOMEDIQ A/S

BIOMEDIQ A/S is a Danish company of the type Aktieselskab based in København K, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SYNARC IMAGING TECHNOLOGY A/S and NORDIC BIOSCIENCE IMAGING A/S. The management consists of Mads Nielsen. The board consists of Pieter Kroese (chair), Mads Nielsen and Martin Lillholm. The company is owned by Screenpoint Medical B.V. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -304,901 and a net result of DKK -977,037 compared with DKK -56,669 the year before. Equity in the 2025 report amounted to DKK -979,433.

Source: annual report 2025, Danish Business Authority